The PARN, TOE1, and USB1 RNA deadenylases and their roles in RNA

被引:5
作者
Huynh, Thao Ngoc [1 ]
Parker, Roy [1 ,2 ]
机构
[1] Univ Colorado, Dept Biochem, Boulder, CO 80309 USA
[2] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
关键词
HOYERAAL-HREIDARSSON SYNDROME; CLERICUZIO-TYPE POIKILODERMA; SMALL NUCLEAR-RNA; POLY(A)-SPECIFIC RIBONUCLEASE PARN; PONTOCEREBELLAR HYPOPLASIA TYPE-2; POLYADENYLIC-ACID SEQUENCES; DYSKERATOSIS-CONGENITA; ACTIVE-SITE; U6; SNRNA; OLIVOPONTOCEREBELLAR HYPOPLASIA;
D O I
10.1016/j.jbc.2023.105139
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The levels of non-coding RNAs (ncRNAs) are regulated by transcription, RNA processing, and RNA degradation pathways. One mechanism for the degradation of ncRNAs involves the addition of oligo(A) tails by non-canonical poly(A) polymerases, which then recruit processive sequence-independent 3' to 5' exonucleases for RNA degradation. This pathway of decay is also regulated by three 3' to 5' exoribonucleases, USB1, PARN, and TOE1, which remove oligo(A) tails and thereby can protect ncRNAs from decay in a manner analogous to the deubiquitination of proteins. Loss-of-function mutations in these genes lead to premature degradation of some ncRNAs and lead to specific human diseases such as Poikiloderma with Neutropenia (PN) for USB1, Dyskeratosis Congenita (DC) for Poand Pontocerebellar Hypoplasia type 7 (PCH7) for TOE1. Herein, we review the biochemical properties of USB1, PARN, and TOE1, how they modulate ncRNA levels, and their roles in human diseases.
引用
收藏
页数:12
相关论文
共 147 条
  • [1] A doughnut-shaped heteromer of human Sm-like proteins binds to the 3′-end of U6 snRNA, thereby facilitating U4/U6 duplex formation in vitro
    Achsel, T
    Brahms, H
    Kastner, B
    Bachi, A
    Wilm, M
    Lührmann, R
    [J]. EMBO JOURNAL, 1999, 18 (20) : 5789 - 5802
  • [2] FATAL INFANTILE ENCEPHALOPATHY WITH OLIVOPONTOCEREBELLAR HYPOPLASIA AND MICRENCEPHALY - REPORT OF 3 SIBLINGS
    ALBRECHT, S
    SCHNEIDER, MC
    BELMONT, J
    ARMSTRONG, DL
    [J]. ACTA NEUROPATHOLOGICA, 1993, 85 (04) : 394 - 399
  • [3] Early Pontocerebellar Hypoplasia With Vanishing Testes: A New Syndrome?
    Anderson, Christopher
    Davies, Justin H.
    Lamont, Lilias
    Foulds, Nicola
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (04) : 667 - 672
  • [4] Transcription termination by the eukaryotic RNA polymerase III
    Arimbasseri, Aneeshkumar G.
    Rijal, Keshab
    Maraia, Richard J.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2013, 1829 (3-4): : 318 - 330
  • [5] The 2'-5' RNA ligase of Escherichia coli - Purification, cloning, and genomic disruption
    Arn, EA
    Abelson, JN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (49) : 31145 - 31153
  • [6] Hoyeraal-Hreidarsson Syndrome: An Extremely Rare Dyskeratosis Congenita Phenotype
    Bakar, Ozgur
    Isik, Ugur
    Canpolat, Cengiz
    Alanay, Yasemin
    [J]. PEDIATRIC DERMATOLOGY, 2015, 32 (06) : e263 - e266
  • [7] Inhibition of mRNA deadenylation by the nuclear cap binding complex (CBC)
    Balatsos, NAA
    Nilsson, P
    Mazza, C
    Cusack, S
    Virtanen, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (07) : 4517 - 4522
  • [8] Barth P G, 2000, Eur J Paediatr Neurol, V4, P161, DOI 10.1053/ejpn.2000.0294
  • [9] Pontocerebellar hypoplasia type 2: a neuropathological update
    Barth, Peter G.
    Aronica, Eleonora
    de Vries, Linda
    Nikkels, Peter G. J.
    Scheper, Wiep
    Hoozemans, Jeroen J.
    Poll-The, Bwe-Tien
    Troost, Dirk
    [J]. ACTA NEUROPATHOLOGICA, 2007, 114 (04) : 373 - 386
  • [10] THE SYNDROME OF AUTOSOMAL RECESSIVE PONTOCEREBELLAR HYPOPLASIA, MICROCEPHALY, AND EXTRAPYRAMIDAL DYSKINESIA (PONTOCEREBELLAR HYPOPLASIA TYPE-2) - COMPILED DATA FROM 10 PEDIGREES
    BARTH, PG
    BLENNOW, G
    LENARD, HG
    BEGEER, JH
    VANDERKLEY, JM
    HANEFELD, F
    PETERS, ACB
    VALK, J
    [J]. NEUROLOGY, 1995, 45 (02) : 311 - 317